Warburg Pincus Co-Leads Latest Funding Round in Israel’s MDClone
This article is for subscribers only.
MDClone, a synthetic medical data startup, raised $63 million from investors led by Warburg Pincus and Viola Growth to fund global expansion.
The Israeli company, which sells artificial databases that closely mirror real world data sets, has started exploring markets in Europe, Asia and the Persian Gulf, Chief Executive Officer Ziv Ofek said in an interview.